Acquired perforating dermatosis: A clinicopathologic study, and the features of dermoscopy and reflective confocal microscopy of 37 cases

[1]  H. Dharmadji,et al.  Coexistent Lichen Amyloidosis and Acquired Reactive Perforating Collagenosis in Type 2 Diabetes Mellitus and Post-Thyroidectomy Hypothyroidism Due to Papillary Thyroid Carcinoma: A Rare Case , 2022, International medical case reports journal.

[2]  S. Alobaida,et al.  Dupilumab in acquired perforating dermatosis: A potential new treatment , 2022, JAAD case reports.

[3]  G. DeLuca,et al.  Natalizumab‐induced acquired perforating dermatosis , 2021, Clinical and experimental dermatology.

[4]  Belkız Uyar,et al.  Dermoscopic Patterns of Acquired Reactive Perforating Collagenosis , 2020, Dermatology practical & conceptual.

[5]  Xiaopo Wang,et al.  Reflectance confocal microscopic appearance of acquired reactive perforating collagenosis , 2020, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

[6]  B. Lebe,et al.  Dermoscopic pattern of Kyrle's disease☆☆☆ , 2020, Anais brasileiros de dermatologia.

[7]  G. Yosipovitch,et al.  The treatment of Kyrle's disease: a systematic review , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[8]  Y. Gilaberte,et al.  Acquired perforating dermatosis: clinicopathological study of 31 cases, emphasizing pathogenesis and treatment , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

[9]  T. Russo,et al.  Dermoscopy of Kyrle disease. , 2016, Journal of the American Academy of Dermatology.

[10]  K. Park,et al.  A Clinicopathologic Study of Thirty Cases of Acquired Perforating Dermatosis in Korea , 2014, Annals of dermatology.

[11]  M. Sachse,et al.  Erworbene reaktive perforierende Dermatose , 2013 .

[12]  R. Hamidi,et al.  Acquired reactive perforating collagenosis associated with papillary thyroid carcinoma: a paraneoplastic phenomenon? , 2010, Clinical and experimental dermatology.

[13]  T. Gambichler,et al.  Up-regulation of transforming growth factor-beta3 and extracellular matrix proteins in acquired reactive perforating collagenosis. , 2009, Journal of the American Academy of Dermatology.

[14]  S. Viswanathan,et al.  RARE PRESENTATION OF KYRLE'S DISEASE IN SIBLINGS , 2008, Indian journal of dermatology.

[15]  M. Chiu,et al.  Acquired perforating dermatosis associated with primary biliary cirrhosis and hashimoto thyroiditis. , 2007, Cutis.

[16]  Y. Saray,et al.  Acquired perforating dermatosis: clinicopathological features in twenty‐two cases , 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

[17]  T. Kawakami,et al.  Immunohistochemical analysis of transforming growth factor‐β3 expression in acquired reactive perforating collagenosis , 2001, The British journal of dermatology.

[18]  J. Patterson.  Progress in the perforating dermatoses. , 1989, Archives of dermatology.

[19]  R. Rapini,et al.  Acquired perforating dermatosis. Evidence for combined transepidermal elimination of both collagen and elastic fibers. , 1989 .